Fatty Liver Disease (FLD) Clinical Trials Fatty Liver Disease (FLD) RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Inventiva Announces Positive Topline Results From the Investigator-Initiated Phase II Clinical Trial Evaluating Lanifibranor in Patients with T2D and NAFLD
Lanifibranor 800mg achieved the primary efficacy endpoint demonstrating a 44% reduction of hepatic fat measured by proton magnetic resonance spectroscopy (1H-MRS) following 24 weeks of treatment in patients with nonalcoholic fatty liver disease... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - June 13, 2023 Category: Pharmaceuticals Source Type: clinical trials

Transient Elastograghy to Detect Non Alcoholic Fatty Liver Disease in Renal Transplantation Recipients.
Conditions:   Non-Alcoholic Fatty Liver Disease;   Renal Transplant Complication Pre-Existing Disease Intervention:   Device: transient elastograghy Sponsor:   Amany Khaled Ali Ahmed Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2023 Category: Research Source Type: clinical trials

Increased Risk of Non-alcoholic Fatty Liver Disease in Low Birth Weight Individuals
Conditions:   Non-Alcoholic Fatty Liver Disease;   Low Birth Weight Intervention:   Sponsors:   Steno Diabetes Center Copenhagen;   Aarhus University Hospital;   Lund University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 6, 2023 Category: Research Source Type: clinical trials